MedTrace Logo

Investigating the Gut Microbiota of Individuals With Adenoma, Advanced Adenoma and Colorectal Cancer

NCT07321548 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1757

Last updated 2026-01-07

No results posted yet for this study

Summary

This observational study aims to help establish the first molecular test for non-invasive prediction of recurrent adenoma, which will help identify patients at high risk of recurrent adenoma for further colonoscopy examination, and validate the microbial test for CRC screening in different populations.

Conditions

Interventions

DIAGNOSTIC_TEST

Fecal immunochemical test

This diagnosis test is commonly used for screening CRC, which can act as an indicator to compare the performance of our new molecular test

Sponsors & Collaborators

  • Institute of Gastroenterology and Hepatology, Vietnam

    collaborator OTHER

  • Mahidol University

    collaborator OTHER

  • National University of Malaysia

    collaborator OTHER

  • Second Affiliated Hospital, School of Medicine, Zhejiang University

    collaborator OTHER

  • Chinese University of Hong Kong

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-03-15
Primary Completion
2024-11-30
Completion
2025-09-30

Countries

  • Hong Kong

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07321548 on ClinicalTrials.gov